Actually, the fact that distal fallopian tubes of women with LFS are exquisitely prone to developing p53 signatures, identical to those described in BRCA1/2-mutations carriers and general population, does not mean an association with ovarian cancer, as at least one more genotoxic event is needed to produce the malignant phenotype [61]. The gene discussed is BRCA1; the disease is ovarian cancer.